12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Other News

Prosonix, Imperial College, King's College, Medical Research Council, University of Bath inflammation, pulmonary, drug delivery news

Prosonix received a grant worth up to £1.3 million ($2.1 million) from the U.K.'s Biomedical Catalyst fund for preclinical development of inhaled combination treatments using Prosonix's...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >